Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Christine Campese is active.

Publication


Featured researches published by Christine Campese.


The Journal of Infectious Diseases | 2006

A Community-Wide Outbreak of Legionnaires Disease Linked to Industrial Cooling Towers—How Far Can Contaminated Aerosols Spread?

Tran Minh Nhu Nguyen; D. Ilef; Sophie Jarraud; Laurence Rouil; Christine Campese; Didier Che; S. Haeghebaert; François Ganiayre; Frédéric Marcel; Jerome Etienne; Jean-Claude Desenclos

A community-wide outbreak of legionnaires disease occurred in Pas-de-Calais, France, in November 2003-January 2004. Eighteen (21%) of 86 laboratory-confirmed cases were fatal. A case-control study identified smoking, silicosis, and spending >100 min outdoors daily as risk factors for acquiring the disease. Legionella pneumophila strain Lens was isolated from cooling towers, wastewater, and air samples from plant A. This unique strain matched all 23 clinical isolates, as assessed by pulsed-field gel electrophoresis subtyping. Modeling of atmospheric dispersion of aerosols emitted from plant A cooling towers showed good coverage of the communes where patients lived and showed that the dispersion extended over a distance of at least 6 km from plant A. No other aerosol-producing installation was identified as a plausible source, and no common source of indoor exposure was found. These findings implicate plant A as the most likely outbreak source and suggest that the distance of airborne transmission of L. pneumophila may be greater than previously reported.


Journal of Clinical Microbiology | 2003

Legionella pneumophila serogroup 1 strain Paris: Endemic distribution throughout France

Helena Aurell; Jerome Etienne; Françoise Forey; Monique Reyrolle; Pascale Girardo; Pierre Farge; Bénédicte Decludt; Christine Campese; François Vandenesch; Sophie Jarraud

ABSTRACT An analysis of 691 French clinical Legionella isolates showed that the endemic L. pneumophila serogroup 1 strain Paris was responsible for 12.2% of all cases of legionellosis and had a specific pulsed-field gel electrophoresis pattern. We also demonstrated the presence of this endemic clone throughout Europe.


Clinical Infectious Diseases | 2004

Risk Factors for Leptospirosis in Metropolitan France: Results of a National Case-Control Study, 1999–2000

Anthony Nardone; I Capek; Guy Baranton; Christine Campese; Daniele Postic; V Vaillant; Michel Lié; Jean-Claude Desenclos

Risk factors for leptospirosis in France were investigated to improve the vaccination program for this disease. Data from 90 hospitalized case patients and 169 matched control subjects were analyzed in a case-control study. Skin lesions, canoeing, contact with wild rodents, and country residence were independently associated with leptospirosis, emphasizing that leisure activity is a risk factor for this illness.


European Respiratory Journal | 2012

Factors associated with hospital mortality in community-acquired legionellosis in France

Christian Chidiac; Didier Che; S. Pires-Cronenberger; Sophie Jarraud; Christine Campese; Bissery A; Weinbreck P; Brun-Buisson C; Sollet Jp; René Ecochard; Desenclos Jc; Jerome Etienne; Philippe Vanhems

The aims of this study were to describe the clinical, biological and radiological features of community-acquired (CA) Legionnaires’ disease (LD) and identify the predictors of mortality in hospitalised patients. Demographic data, risk factors, clinical and biological features, medical management, complications, and outcome from 540 hospitalised patients with confirmed CA LD were prospectively recorded. 8.1% of patients (44 out of 540) died. The predictors of survival after Kaplan–Meier analysis were male sex (p=0.01), age <60 yrs (p=0.02), general symptoms (p=0.006), intensive care unit (ICU) stay (p<0.001), and class II–III Pneumonia Severity Index score (p=0.004). Six predictors of death were identified by multivariate analysis: age (per 10-yr increment) (relative hazard (RH) 1.50, 95% CI 1.21–1.87), female sex (RH 2.00, 95% CI 1.08–3.69), ICU admission (RH 3.31, 95% CI 1.67–6.56), renal failure (RH 2.73, 95% CI 1.42–5.27), corticosteroid therapy (RH 2.54, 95% CI 1.04–6.20) and C-reactive protein (CRP) >500 mg·L−1 (RH 2.14, 95% CI 1.02–4.48). Appropriate antibiotic therapy was prescribed for 70.8% (292 out of 412) of patients after admission and for 99.8% (537 out of 538) of patients after diagnosis confirmation. In conclusion, female sex, age, ICU stay, renal failure, corticosteroid treatment and increased level of CRP are significant risk factors for mortality in CA LD.


Clinical Infectious Diseases | 2009

Host-related risk factors and clinical features of community-acquired legionnaires disease due to the Paris and Lorraine endemic strains, 1998-2007, France.

Christophe Ginevra; Antoine Duclos; Philippe Vanhems; Christine Campese; Françoise Forey; Gerard Lina; Didier Che; Jerome Etienne; Sophie Jarraud

BACKGROUND In France, Legionnaires disease is mainly caused by Legionella pneumophila. Here, we investigated possible host factors associated with susceptibility to community-acquired Legionnaires disease caused by the endemic Paris and Lorraine strains. METHODS We conducted a double-nested exploratory case-control study with use of data from the French national surveillance network of incident Legionnaires disease cases notified from 1998 through 2007. Patients with community-acquired Legionnaires disease and an L. pneumophila serogroup 1 isolate were eligible. Case patients were patients infected by the Paris or Lorraine strain, and control patients were those infected by sporadic strains. Epidemiological and clinical factors associated with infection with the Paris and Lorraine strains were assessed by calculating adjusted odds ratios (aOR) in multivariate logistic regression models. RESULTS We studied 1090 patients infected by sporadic strains (n = 920), the Paris strain (n = 80), or the Lorraine strain (n = 90). Infection with the Paris strain was significantly associated with female sex (aOR, 1.98; 95% confidence interval [CI], 1.19-3.28), steroid therapy (aOR, 3.16; 95% CI, 1.76-5.68), and a history of cancer or hematologic malignancies (aOR, 2.08; 95% CI, 1.15-3.76). In addition, the mortality rate was higher among patients infected with the Paris strain than in the control group (38% vs. 25.5%). The Lorraine strain was associated with smoking (aOR, 1.82; 95% CI, 1.14-2.91) and reduced mortality (9.9%). . CONCLUSION Several host characteristics were associated with the risk of infection by endemic strains of L. pneumophila serogroup 1. These findings may help to guide preventive measures. Factors predisposing patients to infection by specific strains need to be explored further.


Revue Des Maladies Respiratoires | 2004

Situation épidémiologique de la tuberculose en Ile-de-France en 2001.

Didier Che; J. Cailhol; Christine Campese; B Decludt

Resume Introduction En France, l’incidence de la tuberculose est stable autour de 10 cas pour 100 000 habitants depuis 1997. Cependant, l’Ile-de-France, ou la densite de population et le nombre de personnes en situation precaire sont les plus importants, comptabilise a elle seule plus de la moitie des cas declares en France. Methodes Etude descriptive retrospective a partir des donnees de la declaration obligatoire pour l’annee 2001. Resultats L’incidence de la tuberculose etait de 27,2 cas pour 100 000 habitants en 2001 en Ile-de-France et de 48,4 pour 100 000 habitants a Paris. Les sujets les plus touches etaient les sujets jeunes de nationalite etrangere, notamment d’un pays d’Afrique sub-saharienne. Les formes pulmonaires etaient majoritaires et touchaient 72 % des sujets. Une co-infection par le VIH etait documentee pour 7,5 % des sujets. Une demande d’intervention des services de lutte anti-tuberculeuse etait demandee dans moins de 30 % des cas, et pour seulement 50 % des cas vivant en collectivite et ayant une localisation pulmonaire. Conclusion La surveillance epidemiologique ainsi que la lutte anti-tuberculeuse necessitent d’etre renforcee en Ile-de-France, notamment par la mobilisation de l’ensemble des intervenants afin d’ameliorer la reactivite et l’efficacite du dispositif.


Journal of Clinical Microbiology | 2012

Contribution of Amoebic Coculture to Recovery of Legionella Isolates from Respiratory Samples: Prospective Analysis over a Period of 32 Months

Ghislaine Descours; A. Suet; Christophe Ginevra; Christine Campese; S. Slimani; F. Ader; D. Che; Gerard Lina; Sophie Jarraud

ABSTRACT We evaluated the contribution of amoebic coculture to the recovery of Legionella spp. from 379 respiratory samples. The sensitivity of axenic culture was 42.1%. The combination of axenic culture with amoebic coculture increased the Legionella isolation rate to 47.1%. Amoebic coculture was particularly efficient in isolating Legionella spp. from respiratory samples contaminated with oropharyngeal flora.


Archives De Pediatrie | 2003

Les cas de tuberculose déclarés en France en 2001

J. Cailhol; Didier Che; Christine Campese; B Decludt


Eurosurveillance | 2013

First cases of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infections in France, investigations and implications for the prevention of human-to-human transmission, France, May 2013.

A Mailles; Blanckaert K; Chaud P; van der Werf S; Bruno Lina; Caro; Christine Campese; Guéry B; Prouvost H; Lemaire X; M C Paty; S. Haeghebaert; D Antoine; Ettahar N; H. Noel; Behillil S; Hendricx S; Manuguerra Jc; Enouf; La Ruche G; C. Semaille; Bruno Coignard; D Lévy-Bruhl; Weber F; Christine Saura; Didier Che; Investigation team


International Journal of Infectious Diseases | 2011

Progress in the surveillance and control of Legionella infection in France, 1998-2008.

Christine Campese; D. Bitar; Sophie Jarraud; Catherine Maine; Françoise Forey; Jerome Etienne; J C Desenclos; Christine Saura; Didier Che

Collaboration


Dive into the Christine Campese's collaboration.

Top Co-Authors

Avatar

Didier Che

Institut de veille sanitaire

View shared research outputs
Top Co-Authors

Avatar

Sophie Jarraud

École normale supérieure de Lyon

View shared research outputs
Top Co-Authors

Avatar

B Decludt

Institut de veille sanitaire

View shared research outputs
Top Co-Authors

Avatar

D. Che

Institut de veille sanitaire

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Christophe Ginevra

École normale supérieure de Lyon

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

J C Desenclos

Institut de veille sanitaire

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Bruno Coignard

Institut de veille sanitaire

View shared research outputs
Researchain Logo
Decentralizing Knowledge